Company Filing History:
Years Active: 2018-2020
Title: Laszlo Varga: Innovator in Alphavirus Formulations
Introduction
Laszlo Varga is a notable inventor based in Fort Collins, CO (US). He has made significant contributions to the field of virology, particularly in the development of live, attenuated alphavirus formulations. With a total of 2 patents to his name, Varga's work is paving the way for advancements in vaccine technology.
Latest Patents
Varga's latest patents focus on compositions and methods for live, attenuated alphavirus formulations. These embodiments relate to compositions that include one or more live, attenuated alphaviruses, along with methods to reduce inactivation and degradation of the virus. In certain cases, these compositions may serve as vaccine formulations. Additionally, his work includes the use of HEPES buffer, which may also incorporate carbohydrates, gelatin, and salts to enhance the stability of the formulations.
Career Highlights
Laszlo Varga is currently associated with Takeda Vaccines, Inc., where he continues to innovate in the field of vaccine development. His expertise in alphavirus formulations has positioned him as a key player in the research and development of effective vaccines.
Collaborations
Some of Varga's notable coworkers include Dan T Stinchcomb and Jill Ann Livengood. Their collaborative efforts contribute to the ongoing research and advancements in vaccine technology.
Conclusion
Laszlo Varga's contributions to the field of virology and vaccine development are significant. His innovative work on live, attenuated alphavirus formulations is helping to shape the future of vaccine technology.